TADALAFIL / 5mg; 10mg; 20mg Tablet

With regard to erectile function,

8.2 Lactation

Another study reported that Tadalafil 5 mg once daily improved LUTS in men without ED by a magnitude like that observed in men with ED [2]. Once-daily tadalafil 5 mg has been shown to be most effective in enhancing drug-assisted erectile function in men with ED following radical prostatectomy. It also facilitates early recovery of erectile function post-prostatectomy and may help protect against penile structural changes. However, unassisted erectile function does not improve after discontinuation of active therapy for 20mg tadalafil price nine months [18]. Tadalafil monotherapy significantly improves both storage and voiding lower urinary tract symptoms (LUTS) and enhances the International Prostate Symptom Score (IPSS) [12].

Additional file 6: (download PDF )

To determine the potential benefits of initiating tadalafil early after TURP, we conducted this study to evaluate the efficacy of daily tadalafil 5 mg in managing persistent storage symptoms and improving erectile function post-TURP. Following approval by the institutional ethics committee, this study was conducted at a tertiary care hospital between May 2021 and October 2022. Patients diagnosed with benign prostatic hyperplasia (BPH) who underwent transurethral resection of the prostate (TURP), either monopolar or bipolar, were eligible for inclusion. Informed consent was obtained from all participants prior to enrollment. Patients were then randomized into two groups: Group A received tadalafil 5 mg once daily, while Group B received a placebo.

Missed Dose

All patients included in the study were sexually active prior to undergoing TURP. Patients who were sexually inactive were excluded from analyses related to sexual function, due to the recognized limitations of the International Index of Erectile Function (IIEF-5) in evaluating erectile function among sexually inactive men. A comprehensive medical history was obtained for each participant. Evaluations included the IIEF-5 questionnaire for erectile function, the International Prostate Symptom Score (IPSS), and the IPSS storage symptom subscore-15 for assessing storage symptoms. Additional assessments included uroflowmetry, pelvi-abdominal ultrasonography with post-void residual (PVR) urine measurement, and laboratory investigations (urinalysis, urine culture, renal function tests, complete blood count, coagulation profile, and prostate-specific antigen [PSA] level). there was no statistically significant difference

in baseline IIEF-5 scores between

8.5 Geriatric Use

Moreover, LUTS themselves serve as an independent risk factor for ED, significantly compromising quality of life (QoL). The underlying pathophysiological mechanisms linking LUTS secondary to BPH and ED remain incompletely understood, although both conditions share several common determinants [9, 16]. Transurethral resection of the prostate (TURP) remains the gold standard for managing benign prostatic hyperplasia (BPH), despite the introduction of newer minimally invasive surgical techniques [5, 22]. However, the impact of TURP on sexual function remains uncertain. While some studies report a negative effect, others suggest an improvement in sexual function among patients with ED [19, 26].

News Türkiye's Leading Pharmaceutical Company Expands its Portfolio and Presence in Consumer Health

TURP may contribute to erectile dysfunction pills tadalafil ED through various mechanisms, primarily due to thermal injury affecting the cavernous nerves during surgery. Additional factors include the psychological impact of the procedure and the temporary cessation of sexual activity in the postoperative period [24]. Previous studies have reported that some patients experience persistent irritative symptoms following TURP, requiring postoperative medication to manage ongoing urinary symptoms. These symptoms significantly impact patients'quality of life after surgery. When selecting candidates for TURP, predicting the persistence of irritative bladder symptoms is crucial; however, studies investigating prognostic factors for bladder irritation remain limited.

Impact of patient characteristics and comorbidities on erectile function and treatment satisfaction during treatment with tadalafil OaD

According to recent research, severe preoperative irritative bladder symptoms or frequent nocturia may increase the likelihood of persistent postoperative symptoms [11]. Phosphodiesterase type 5 inhibitors (PDE5-Is) were initially approved for the treatment of ED; however, they have also been shown to be highly effective in alleviating LUTS in men, regardless of the presence of ED [3, 17, 20, 23]. PDE5-Is promote relaxation of the bladder neck and prostate by increasing nitric oxide levels in smooth muscle, thereby directly influencing micturition phases in addition to their role in penile erection [6, 7]. Another study indicates that a once-daily dose of 5 mg tadalafil is a potentially effective, well-tolerated, and safe treatment option for patients with LUTS [4]. Tadalafil 5 mg once daily is currently approved for the treatment of LUTS, regardless of the presence of coexisting ED [16]. the two groups (p = 0.131).

• The drug is available by prescription only.
• It is essential to discuss health history with your doctor.
• Not suitable for individuals with certain eye or heart conditions.

In Group A, a significant improvement

• In rare cases, tadalafil can cause vision changes.
• Allergic reactions may include rash, swelling, or difficulty breathing.
• Seek medical advice if side effects are severe or persistent.

in IIEF-5 scores was observed following TURP.

Ethics declarations

All enrolled patients underwent TURP and were randomly assigned to one of two groups: Group A received tadalafil (5 mg once daily) postoperatively, while Group B received a placebo. Erectile function was assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire, and LUTS were evaluated using the International Prostate Symptom Score (IPSS). The study was conducted at a tertiary care hospital between May 2021 and October 2022. A total of 195 patients were enrolled and randomized into two groups: Group A (n = 103), which received tadalafil 5 mg once daily, and Group B (n = 92), which received a placebo. The mean ± standard deviation (SD) scores for the International Index of Erectile Function (IIEF-5) in Group A at 1, 3, and 6 months post-TURP were 11.59 ± 1.90, 19.80 ± 1.12, and 20.97 ± 0.72, respectively.

Drug Interactions

In Group B, the corresponding scores were 4.88 ± 0.82, 12.86 ± 1.56, and 15.32 ± 1.28. These differences were statistically significant (P < 0.001). Similarly, the mean ± SD values for the International Prostate Symptom Score (IPSS) in Group A at 1, 3, and 6 months post-TURP were 7.31 ± 1.66, 4.46 ± 0.97, and 2.33 ± 0.69, respectively, compared to 9.62 ± 3.34, 5.40 ± 1.98, and 2.83 ± 1.27 in Group B (P < 0.001). Regarding storage symptom subscores, Group A demonstrated preoperative and postoperative mean ± SD values of 8.63 ± 1.82, 3.05 ± 0.78, 1.63 ± 0.49, and 0.92 ± 0.67 at preoperative, 1, 3, and 6 months, respectively. In contrast, Group B showed corresponding values of 3.22 ± 0.72, 2.48 ± 0.50, and 1.69 ± 0.47.

News Abdi İbrahim, Türkiye's Leading Pharmaceutical Company, Extends its Ambitions Into Digital Health

These differences were also statistically significant (P < 0.001). Tadalafil 5 mg daily as monotherapy following TURP can lead to early improvement in erectile function; however, its effect on persistent storage lower urinary tract symptoms (LUTS) post-TURP appears to be modest. Our study has been approved by local ethical committee Kafrelsheikh university(MKSU50-3–1) on 20/5/2021 and by clinical trials (NCT06788704) on 25/1/2025. La fonction érectile a été évaluée à l’aide du questionnaire de l’International Index of Erectile Function-5 (IIEF-5), et les LUTS ont été évalués à l’aide de l’International Prostate Symptom Score (IPSS). Men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) have a higher incidence of erectile dysfunction (ED) [1].